U.S. Chemicals Stock News

We feel now is a pretty good time to analyse LifeStance Health Group, Inc.'s ( NASDAQ:LFST ) business as it appears the...

On October 22, 2025, DataVault AI, Inc. and Wellgistics Health, Inc. announced a non-binding letter of intent to integrate manufacturer-to-patient blockchain-enabled smart contracts into Wellgistics' prescription drug infrastructure, aiming to fully digitize tracking from script to fulfillment across more than 6,500 pharmacies nationwide. A unique aspect of this partnership is its focus on leveraging AI agents and digital routing tools to optimize prescription drug services while enhancing...

Ventyx Biosciences recently announced positive topline results from its Phase 2 clinical trial of VTX3232, showing significant reductions in key inflammatory biomarkers such as hsCRP and IL-6 in patients with obesity and cardiovascular risk factors. An interesting insight from the study is that VTX3232 achieved a robust safety and tolerability profile, both as a standalone therapy and in combination with semaglutide, highlighting its potential as a new oral anti-inflammatory option in...

Bullish momentum is building around Churchill Capital Corp X (CCCX) as options traders pile into call contracts. Volumes have doubled the norm and implied volatility is spiking. The extremely low Put/Call Ratio suggests that optimism is widespread. See our latest analysis for Churchill Capital Corp X. After a quiet start to the year, Churchill Capital Corp X’s share price has climbed significantly in recent weeks, notching a 51.8% gain over the past month and doubling since the beginning of...

MoneyGram Haas F1 Team recently announced a new partnership with CSG Systems International, debuting their collaboration at the 2025 Formula 1 United States Grand Prix in Austin, Texas, to emphasize their shared commitment to innovation and performance. This partnership leverages the global exposure and fast-paced environment of Formula 1 racing to highlight CSG's expertise in empowering brands to engage customers and manage complexity. We'll now examine how CSG's new Formula 1 alliance...

Arcturus Therapeutics Holdings (ARCT) drew intense investor attention after it released interim results from a Phase 2 trial for its cystic fibrosis treatment, ARCT-032. The report showed no substantial lung function improvement, which triggered sharp share declines and analyst downgrades. See our latest analysis for Arcturus Therapeutics Holdings. It has been a turbulent year for Arcturus Therapeutics. Shares have dropped sharply after underwhelming trial news and legal scrutiny, leading to...

Coya Therapeutics has completed a $20 million follow-on equity offering. The company aims to strengthen its cash position and accelerate progress in the Phase 2 trial of COYA 302, its experimental ALS therapy. Investors are watching these milestones closely, as the FDA's recent acceptance of Coya's drug application and a triggered milestone payment bring new attention to the company’s clinical and financial strategy. See our latest analysis for Coya Therapeutics. After announcing the equity...

ETHZilla is drawing attention after unveiling a $15 million strategic partnership with Satschel, Inc., parent of Liquidity.io. This collaboration gives ETHZilla a 15% equity stake as well as exclusive rights within regulated digital asset markets. See our latest analysis for ETHZilla. Momentum has picked up again for ETHZilla after the Satschel investment, with the share price jumping 17.38% in just the last day and 7.32% over the past week, though recent news-fueled rallies come against the...

Earlier this week, Luminar Technologies announced that its lidar technology is now integrated into Volvo’s EX90 and is being included on platforms from Mercedes-Benz, NVIDIA, and Mobileye, while it also provided updates on its next-generation “Halo” chipset and production plans for late 2025 and early 2026. An interesting takeaway is that despite these prominent partnerships and advancements, the company revised its full-year 2025 guidance downward due to slower automotive ramp-up, winding...

Eightco Holdings (ORBS) is in the spotlight again after its move to adopt Worldcoin as a primary reserve asset and bring Dan Ives on board as chairman. This shake-up has sparked renewed interest and rapid price swings. See our latest analysis for Eightco Holdings. ORBS has seen one of the most dramatic runs among speculative stocks this year, with the 1-year total shareholder return at nearly 231%. Yet, this surge comes after years of heavy losses, a delisting, and repeated pivoting between...

Flux Power Holdings (FLUX) has regained compliance with Nasdaq’s listing rules after facing a potential delisting. This development is likely to boost investor confidence and renew interest in the company’s prospects. See our latest analysis for Flux Power Holdings. Regaining Nasdaq compliance comes after a dramatic surge in Flux Power Holdings’ share price, with a 30-day share price return of 85.5% and a striking year-to-date gain of 252.9%. That momentum has reignited interest, especially...

Picard Medical (PMI) shares dropped sharply after the company’s recent SEC filing revealed an expanded equity incentive plan. The filing increased authorized shares and added new types of stock awards, sparking fresh concerns over possible shareholder dilution. See our latest analysis for Picard Medical. The latest shakeup at Picard Medical comes on the heels of its recent IPO and the unveiling of new patents for its artificial heart technology. However, none of that cushioned the blow from...

Despite the fact that PubMatic, Inc. (NASDAQ:PUBM) stock rose 10% last week, insiders who sold US$319k worth of stock...

The recent 10% drop in Marten Transport, Ltd.'s ( NASDAQ:MRTN ) stock could come as a blow to insiders who purchased...

Key Insights LSB Industries' estimated fair value is US$12.94 based on 2 Stage Free Cash Flow to Equity LSB Industries...

While it may not be enough for some shareholders, we think it is good to see the AMC Networks Inc. ( NASDAQ:AMCX...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Key Insights The projected fair value for Lear is US$143 based on 2 Stage Free Cash Flow to Equity Lear is estimated to...

With a median price-to-earnings (or "P/E") ratio of close to 19x in the United States, you could be forgiven for...

Aptera Motors has officially transitioned to a Public Benefit Corporation. This move ties its governance to sustainability goals in solar electric vehicle development. The company also strengthened its Board by appointing two industry veterans. See our latest analysis for Aptera Motors. Aptera’s latest flurry of leadership changes, index inclusion, and new share filings has certainly kept it in the headlines, and the stock has responded in kind. After surging over 50% in the past week,...

Quantum (QMCO) is making headlines after revealing major accounting issues that have led to the need for restating previous financial statements. These developments, which include the CEO's resignation, have sparked multiple class action lawsuits and weighed on investor confidence. See our latest analysis for Quantum. With Quantum under the microscope after its accounting revelations and CEO exit, the share price has staged a modest rebound in the past 90 days, returning nearly 18%. However,...

Ready Capital (RC) shares dropped nearly 30% after the company reported quarterly results that did not meet expectations. This decline came as slower growth in net interest income and falling earnings per share have raised new questions about its long-term profitability. See our latest analysis for Ready Capital. After a steep 30% share price drop over the last month, Ready Capital's recent losses have only compounded a tough year. Its year-to-date share price return stands at -54.8%, with a...

Provident Bancorp (PVBC) reported a net profit margin of 20.2%, more than doubling from 9.6% the previous year and highlighting a significant improvement in profitability. Earnings growth for the past twelve months came in at 136.1%, far surpassing the company’s five-year average, though longer-term earnings have actually declined by an average of 8.2% per year. Looking ahead, consensus calls for earnings to decrease 3.8% annually over the next three years and for revenue to grow just 1.7%...